TLR9 and breast carcinoma: Similarly, both pamidronate and alendronate were stronger inducers of growth inhibition in TLR9 shRNA 4T1 mouse mammary carcinoma cells, as compared with the corresponding control shRNA cells (Supplementary Figure S3).